Reversed glucose and fatty acids transporter expression in human endometrial cancer

Hormone and Metabolic Research

Volumn 44, Issue 6, 2012, Pages 436-441

  Knapp, P ^a   Chabowski, A ^a   Harasiuk, D ^a   Gorski J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

endometrial cancer; FABPpm; FAT CD36; GLUT 1; GLUT 3; GLUT 4

Indexed keywords

CD36 ANTIGEN; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; MESSENGER RNA;

ADULT; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; FEMALE; GLUCOSE INTAKE; GLUCOSE UTILIZATION; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BLOTTING, WESTERN; ENDOMETRIAL NEOPLASMS; FATTY ACIDS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; HUMANS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84861652568     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1301301     Document Type: Article

References (38)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun M J. Cancer statistics. Cancer J Clin: 2008; 58 71 96
2. Bokhman J V. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol: 1983; 15 10 17 (Pubitemid 13194678)
3. th edition. New York W. H. Freeman: 2000
4. Wooda St, Trayhurna P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr: 2003; 89 3 9
5. Hamilton J A. New insights into the roles of proteins and lipids in membrane transport of fatty acids. Prostaglandins Leukot Essent Fatty Acids: 2007; 77 355 361 (Pubitemid 350198863)
6. Bonen A, Chabowski A, Luiken J J, Glatz J F. Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology (Bethesda): 2007; 22 15 29
7. Schaap F G, Hamers L, Van der Vusse G J, Glatz JF C. Molecular cloning of fatty acid transport protein cDAN from rat. Biochim Biophys Acta: 1997; 1354 29 34 (Pubitemid 27479889)
8. Diede H E, Rodilla-Sala E, Gunawan J, Manns M, Stremmel W. Identification and characterization of a monoclonal antibody to the membrane fatty acid binding protein. Biochim Biophys Acta: 1992; 1125 13 20
9. Abumrad N A, El-Maghrabi M R, Amri E-Z, Lopez E, Grimaldi P. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem: 1993; 268 17665 17668 (Pubitemid 23260267)
10. von Wolff M, Ursel S, Hahn U, Steldinger R, Strowitzki T. Glucose transporter proteins (GLUT) in human endometrium: expression, regulation, and function throughout the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab: 2003; 88 3885 3892 (Pubitemid 37034543)
11. Duttaroy A K. Transport of fatty acids across the human placenta: a review. Prog Lipid Res: 2009; 48 52 61
12. Warburg O. On the origin of cancer cells. Science: 1956; 123 309 314
13. Ristow M. Oxidative metabolism in cancer growth. Curr Opin Clin Nutr Metab Care: 2006; 9 339 345 (Pubitemid 44097804)
14. DeBerardinis R J, Lum J J, Hatzivassiliou G, Thompson C B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab: 2008; 7 11 20
15. Holm E, Hagmüller E, Staedt U, Schlickeiser G, Günther H J, Leweling H, Tokus M, Kollmar H B. Substrate balances across colonic carcinomas in humans. Cancer Res: 1995; 55 1373 1378
16. Ogunbiyi O A, Flanagan F L, Dehdashti F, Siegel B A, Trask D D, Birnbaum E H, Fleshman J W, Read T E, Philpott G W, Kodner I J. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. Am J Roentgenol: 1997; 168 417 424 (Pubitemid 27051977)
17. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, Schmidt K, Willson J K, Markowitz S, Zhou S, Diaz L A Jr, Velculescu V E, Lengauer C, Kinzler K W, Vogelstein B, Papadopoulos N. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science: 2009; 325 5947 1555 1559
18. Villavicencio A, Bacallao K, Avellaira C, Gabler F, Fuentes A, Vega M. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia. Gynecol Oncol: 2006; 103 307 314 (Pubitemid 44389871)
19. Avellaira C, Villavicencio A, Bacallao K, Gabler F, Wells P, Romero C, Vega M. Expression of molecules associated with tissue homeostasis in secretory endometria from untreated women with polycystic ovary syndrome. Hum Reprod: 2006; 21 3116 3121 (Pubitemid 44811612)
20. Pfaffl M W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res: 2001; 29 2003 2007
21. Ortega A D, Sánchez-Aragó M, Giner-Sánchez D, Sánchez-Cenizo L, Willers I, Cuezva J M. Glucose avidity of carcinomas. Cancer Lett: 2009; 276 125 135
22. Goldman N A, Katz E B, Glenn A S, Weldon R H, Jones J G, Lynch U, Fezzari M J, Runowicz C D, Goldberg G L, Charron M J. GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma. Mod Pathol: 2006; 19 1429 1436 (Pubitemid 44624161)
23. Medina R A, Meneses A M, Vera J C, Gúzman C, Nualart F, Rodriguez F, de los Angeles Garcia M, Kato S, Espinoza N, Monsó C, Carvajal A, Pinto M, Owen G I. Differential regulation of glucose transporter expression by estrogen and progesterone in Ishikawa endometrial cancer cells. J Endocrinol: 2004; 182 467 478 (Pubitemid 39276214)
24. Airley R E, Mobasheri A. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy: 2007; 53 233 256 (Pubitemid 47074647)
25. Watson R T, Pessin J E. Intracellular organization of insulin signaling and GLUT4 translocation. Recent Prog Horm Res: 2001; 56 175 193
26. Fornes R, Ormazabal P, Rosas C, Gabler F, Vantman D, Romero C, Vega M. Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia. Mol Med: 2010; 16 129 136
27. Gojnic M, Dugalic V, Brankovic M, Stojanovic I, Acimovic M, Vasiljevic B. Is insulin-dependent diabetes and obesity a predisposition for endometrial and pancreatic carcinoma? Clin Exp Obstet Gynecol: 2010; 37 152 154
28. Rosato V, Zucchetto A, Bosetti C, Dal Maso L, Montella M, Pelucchi C, Negri E, Franceschi S, La Vecchia C. Metabolic syndrome and endometrial cancer risk. Ann Oncol: 2011; 22 884 889
29. Koch M, Hussein F, Woeste A, Gründker C, Frontzek K, Emons G, Hawighorst T. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo. Breast Cancer Res Treat: 2010; 128 565 572
30. Yan J, Gong Y, Wang G, Gong Y, Burczynski F J. Regulation of liver fatty acid binding protein expression by clofibrate in hepatoma cells. Biochem Cell Biol: 2010; 88 957 967
31. Kuemmerle N B, Rysman E, Lombardo P S, Flanagan A J, Lipe B C, Wells W A, Pettus J R, Froehlich H M, Memoli V A, Morganelli P M, Swinnen J V, Timmerman L A, Chaychi L, Fricano C J, Eisenberg B L, Coleman W B, Kinlaw W B. Lipoprotein lipase links dietary fat to solid tumor cell proliferation. Mol Cancer Ther: 2011; 10 427 436
32. Blask D E, Brainard G C, Dauchy R T, Hanifin J P, Davidson L K, Krause J A, Sauer L A, Rivera-Bermudez M A, Dubocovich M L, Jasser S A, Lynch D T, Rollag M D, Zalatan F. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Res: 1999; 59 4693 4701 (Pubitemid 29428978)
33. Schimanski S, Wild P J, Treeck O, Horn F, Sigruener A, Rudolph C, Blaszyk H, Klinkhammer-Schalke M, Ortmann O, Hartmann A, Schmitz G. Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissue. Horm Metab Res: 2010; 42 102 109
34. Shirato K, Nakajima K, Korekane H, Takamatsu S, Gao C, Angata T, Ohtsubo K, Taniguchi N. Hypoxic regulation of glycosylation via the N-acetylglucosamine cycle. J Clin Biochem Nutr: 2011; 48 20 25
35. Gayther S A, Barski P, Batley S J, Li L, de Foy K A, Cohen S N, Ponder B A, Caldas C. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours. Oncogene: 1997; 15 2119 2126 (Pubitemid 27489138)
36. Lee M P, Feinberg A P. Aberrant splicing but not mutations of TSG101 in human breast cancer. Cancer Res: 1997; 57 3131 3134 (Pubitemid 27351724)
37. Chabowski A, Górski J, Bonen A. Regulation of fatty acid transport: from transcriptional to posttranscriptional effects. Naunyn Schmiedebergs Arch Pharmacol: 2006; 373 259 263 (Pubitemid 43999777)
38. Dutta-Roy A K. Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta. Am J Clin Nutr: 2000; 71 1 Suppl 315S 322S (Pubitemid 30046134)